At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ECOR Electrocore LLC
Post-Market Trading 11-15 18:24:01 EST
10.94
-2.66
-19.56%
盘后11.15
+0.21+1.92%
17:22 EST
High13.93
Low10.76
Vol199.17K
Open13.70
D1 Closing13.60
Amplitude23.31%
Mkt Cap70.53M
Tradable Cap48.68M
Total Shares6.45M
T/O2.34M
T/O Rate4.48%
Tradable Shares4.45M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
U.S. RESEARCH ROUNDUP- Applied Materials, Disney, Walmart
electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.